FDA Announces Change in Status of 12 Peptides SSRP Institute Upcoming FDA APPROVALS : March April 2026 . : r biotech_stocks In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Decisions to Look For in 1H 2026 CGTlive EllieMD Dihexa FDA 2025 Approvals: Innovation and Next Gen Blockbuster Drugs Biopharma PEG